NCT05515068Not yet recruiting
Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas
Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas (COSS-Registry)
Source: ClinicalTrials.gov · Last updated 25 Aug 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas (COSS-Registry) is a non-interventional, multicentric, international, clinical and epidemiologic patient registry. The COSS-Registry collects key data on osteosarcomas or biologically related bone sarcomas. With that data collection we want to gain new scientific insights and results about this tumor disease, prognosis, surveillance and long-term effects. Besides the data collection we would also like to foster the collection of biomaterial (tumor specimen and blood samples) for scientific research. The stored material will be used to perform cell and molecular biological analyses to identify the causes of osteosarcoma, the prognosis and possible new treatment options. As a starting point the donated biomaterial of registered patients will be analyzed firstly for the presence of a tumor predisposition by germline mutations. In case of detected genetic variations that are related to the tumor disease and which may affect the patient's health and follow-up care (because of the potentially increased risk of developing other malignant tumors), affected patients will be informed and referred to genetic counseling. Registry patients will be asked at the time of diagnosis if they wish to be informed about germline variants detected as part of the study procedures.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 16 Aug 2022
- Start date
- Sept 2022
- Primary completion date
- Mar 2032
- Lead sponsor
- Klinikum Stuttgart
- Diseases
- Childhood cancers, Sarcoma
- NCT number
- NCT05515068
What you commit to
- Study type: Observational
- Planned participants: 1000
- From Sept 2022 to the primary completion date, Mar 2032
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- no informed consent
Who the study is looking for
- high-grade osteosarcoma (conventional and non-conventional)
- parosteal, periosteal or extraosseous osteosarcoma
- low grade central osteosarcoma
- (osseous) Undifferentiated pleomorphic sarcoma (UPS)
- (osseous) leiomyosarcoma
- (osseous) dedifferentiated chondrosarcoma
- (osseous) mesenchymal chondrosarcoma
- (osseous) fibrosarcoma
- (osseous) angiosarcoma
- informed consent
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.